| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a313856c16664ca59b8387507cacbfef
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eb258be6a48fd6826b8c923ea4234dff |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-112
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-81
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-705 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-81
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886 |
| filingDate |
2017-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_547eb8cebe5993857dcdb3814b534e2b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_401d79c301d3e6e922918b673654b1b5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f335b34ae4af58c08b2b51ca428666dd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_66698c378981011982e41c98c3b00228
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9a03d65531d7b52e7184063ee7888bfa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e27abc9d88ad45251e4a8dd03fb85d3b |
| publicationDate |
2019-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-109863251-A |
| titleOfInvention |
Methods for subtyping lung squamous cell carcinoma |
| abstract |
Methods and compositions are provided for determining an individual's lung squamous cell carcinoma (SQ) subtype by detecting the expression level of at least one classifier biomarker selected from a panel of lung squamous cell carcinoma gene signatures. Also provided herein are methods and compositions for determining the response of an individual with a squamous cell carcinoma subtype to therapy such as immunotherapy. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112433054-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111755073-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111755073-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111369501-A |
| priorityDate |
2016-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |